POLR2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.8535000442036E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.61099999971415E-07 |
Normal-vs-Stage2 |
6.551900E-04 |
Normal-vs-Stage3 |
1.05629949231911E-11 |
Normal-vs-Stage4 |
3.1901999999473E-06 |
Stage1-vs-Stage2 |
7.432200E-01 |
Stage1-vs-Stage3 |
1.020830E-04 |
Stage1-vs-Stage4 |
1.125830E-01 |
Stage2-vs-Stage3 |
5.897800E-02 |
Stage2-vs-Stage4 |
3.799200E-01 |
Stage3-vs-Stage4 |
3.642600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.50190000436368E-08 |
Normal-vs-AfricanAmerican |
1.53947000000043E-05 |
Normal-vs-Asian |
2.238400E-01 |
Caucasian-vs-AfricanAmerican |
9.598000E-01 |
Caucasian-vs-Asian |
3.834400E-01 |
AfricanAmerican-vs-Asian |
3.175400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.68819999383174E-09 |
Normal-vs-Female |
1.30430000000459E-06 |
Male-vs-Female |
4.639800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.97060000000682E-05 |
Normal-vs-Age(41-60Yrs) |
1.55950000002569E-06 |
Normal-vs-Age(61-80Yrs) |
1.4226000044637E-08 |
Normal-vs-Age(81-100Yrs) |
2.30499999998024E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.350200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.741200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.412000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.519600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.025240E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.499800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.113000E-01 |
Normal-vs-Grade 2 |
2.02549999999135E-05 |
Normal-vs-Grade 3 |
4.40659730926996E-11 |
Normal-vs-Grade 4 |
1.49070000010632E-07 |
Grade 1-vs-Grade 2 |
1.830840E-01 |
Grade 1-vs-Grade 3 |
1.115650E-02 |
Grade 1-vs-Grade 4 |
1.979550E-03 |
Grade 2-vs-Grade 3 |
2.715300E-03 |
Grade 2-vs-Grade 4 |
1.062040E-02 |
Grade 3-vs-Grade 4 |
3.685000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.242010E-04 |
Normal-vs-ccB subtype |
1.94570004552475E-09 |
ccA subtype-vs-ccB subtype |
4.221500E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
8.60059999996388E-07 |
Normal-vs-N1 |
1.248430E-01 |
N0-vs-N1 |
7.758600E-01 |
|
|